Fluidigm Q2 Revenues Rise 58 Percent on Contribution of DVS Acquisition | GenomeWeb

NEW YORK (GenomeWeb) – Fluidigm's second quarter revenues jumped 58 percent year over year, or 32 percent organically, the company reported after the close of the market on Thursday.

For the three months ended June 30, Fluidigm's total revenues increased to $27.6 million from $17.5 million in the year-ago quarter and beat the consensus analysts' estimate of $27.1 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."